Harvard Business Review

JUNE 16, 2011

Interestingly, intangible assets are all the rage these days on Wall Street. Interestingly, intangible assets are all the rage these days on Wall Street. Most intangible assets are real but invisible, and the most important invisible ability is the ability (or, perhaps better said, the probability) to collaborate.

Intangible Assets 15

Intangible Assets Analysis Pharmaceuticals Innovation 15

Harvard Business Review

APRIL 7, 2014

To answer that question, we compared the performance of 148 publicly listed family-owned companies between 2000 and 2009 with that of 127 non-family businesses using Standard & Poor’s Compustat database. Family-owned businesses did not hold back on new product launches during the recessions. during the growth years to 0.8

First-mover Advantage 9

First-mover Advantage Intangible Assets Sample Metrics 9

Harvard Business Review

NOVEMBER 21, 2013

Wyeth, a pharmaceutical acquired by Pfizer in 2009, was the sole supplier of Premarin. In 1998, a group of horse ranchers suddenly set up a production facility and filed an Abbreviated New Drug Application (ANDA) for a generic version of Premarin. This, of course, represented a serious threat to a hugely profitable product.

Intangible Assets 8

Intangible Assets Merchandising Innovation Pharmaceuticals 8